Search Within

Harry W Herr

  1. "Biostatistics Service"
Formats
  1. Journal Article (22)
  2. Meeting Abstract (8)
  3. Correspondence (2)
  4. Conference Paper (1)
Groups
  1. Biostatistics Service (33)
  2. Epidemiology and Biostatistics (33)
  3. Surgery (33)
  4. Urology (33)
  5. Department of Medicine (19)
  6. Genitourinary Oncology Service (19)

More Groups

People
  1. Bernard Bochner (20)
  2. Guido Dalbagni (20)
  3. Sherri Donat (20)
  4. Dean Bajorin (17)
  5. Irina Ostrovnaya (14)
  6. Ashley Regazzi (12)

More People

Years
  1. 2024 (2)
  2. 2023 (3)
  3. 2022 (4)
  4. 2021 (1)
  5. 2020 (2)
  6. 2019 (1)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal of Urology (5)
  3. Urology (3)
  4. Clinical Genitourinary Cancer (2)
  5. JCO Precision Oncology (2)
  6. American Journal of Epidemiology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (12)
  2. Elsevier Science, Inc. (9)
  3. Elsevier Inc. (3)
  4. Oxford University Press (3)
  5. American Association for Cancer Research (1)
  6. American Roentgen Ray Society (1)

More Publishers

Results (33)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neoadjuvant gemcitabine-cisplatin plus radical cystectomy-pelvic lymph node dissection for muscle-invasive bladder cancer: A 12-year experience
    Journal Article

    Iyer, G.; Tully, C. M.; Zabor, E. C.; Bochner, B. H.; Dalbagni, G.; Herr, H. W.; Donat, S. M.; Russo, P.; Ostrovnaya, I.; Regazzi, A. M.; more...
    Clinical Genitourinary Cancer (2020)

    Fulltext@MSK | Save
  • Goal-directed versus standard fluid therapy to decrease ileus after open radical cystectomy: A prospective randomized controlled trial
    Journal Article

    Arslan-Carlon, V.; Tan, K. S.; Dalbagni, G.; Pedoto, A. C.; Herr, H. W.; Bochner, B. H.; Cha, E. K.; Donahue, T. F.; Fischer, M.; Donat, S. M.
    Anesthesiology (2020)

    Fulltext@MSK | Save
  • Propensity-matched analysis of patient-reported outcomes for neoadjuvant chemotherapy prior to radical cystectomy
    Journal Article

    Feuerstein, M. A.; Goldstein, L.; Reaves, B.; Sun, A.; Goltzman, M.; Morganstern, B. A.; Shabsigh, A.; Bajorin, D. F.; Rosenberg, J. E.; Donat, S. M.; more...
    World Journal of Urology (2019)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)
    Meeting Abstract

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Gemcitabine-cisplatin (GC) plus radical cystectomy-pelvic lymph node dissection (RC-PLND) for patients (pts) with muscle-invasive bladder cancer (MIBC): Assessing impacts of neoadjuvant chemotherapy (NAC) and the PLND
    Meeting Abstract

    Tully, C. M.; Bochner, B. H.; Dalbagni, G.; Zabor, E. C.; Herr, H. W.; Donat, S. M.; Ostrovnaya, I.; Regazzi, A. M.; Kim, P. H.; Sfakianos, J. P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Meeting Abstract

    Balar, A. V.; Iyer, G.; Apolo, A. B.; Regazzi, A. M.; Garcia-Grossman, I. R.; Pendse, D.; Ostrovnaya, I.; Chou, J. F.; Bochner, B.; Dalbagni, G.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Single nucleotide polymorphisms as markers of bacillus Calmette-Guerin intravesical therapy response in non-muscle invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Hamilton, R. J.; Joseph, V.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Gallagher, D. J.; Pendse, D.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Association of single-nucleotide polymorphisms in BCL2L1 and TACC3 with response to bacillus Calmette-Guerin intravesical therapy in non-muscle-invasive bladder cancer
    Meeting Abstract

    Alanee, S.; Gallagher, D. J.; Vijai, J.; Hamilton, R. J.; Ostrovnaya, I.; Garcia-Grossman, I. R.; Riches, J. C.; Regazzi, A. M.; Przybylo, J. A.; Gaudet, M.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save